These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39167910)

  • 1. Survival analysis of gynecological cancers in Southeast China, 2011-2020: A population-based study.
    Deng S; Zhou Y; Lin J; Xiang Z; Liu L; Xie N; Yu H; Sun Y
    Cancer Epidemiol; 2024 Oct; 92():102641. PubMed ID: 39167910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002-2013.
    Jiang YF; Jiang Y; Bi JH; Zhang Y; Zheng WW; Zhou XH; Wu J; Yuan HY; Zhao WS; Xiang YB
    Cancer Epidemiol; 2023 Jun; 84():102355. PubMed ID: 36989956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of survival rate of breast, cervical, and ovarian cancer patients during 2005-2010 in Zhejiang province, China].
    Gong W; Luo S; Hu R; Wang H; Pan J; Fei F; He Q; Yu M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 May; 48(5):366-9. PubMed ID: 24985374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Survival Trend of Gynecological Cancer: A Systematic Review of Population-Based Cancer Registration Data.
    Zhou XH; Yang DN; Zou YX; Tang DD; Chen J; Li ZY; Shen QM; Xu Q; Xiang YB
    Biomed Environ Sci; 2024 Aug; 37(8):897-921. PubMed ID: 39198254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of gynecological cancers in Turkey: where are we at?
    Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
    J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and mortality for gynaecological cancers in Southeastern China during 2011-2020: a retrospective analysis of registry data.
    Liu L; Zhou Y; Lin J; Xie N; Yu H; Deng S; Sun Y
    BMJ Open; 2024 Sep; 14(9):e083336. PubMed ID: 39343456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Danish cancer patients 1943-1987. Female genital organs.
    Kjaer SK; Storm HH
    APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urban-rural differences of gynaecological malignancies in Egypt (1999-2002).
    Dey S; Hablas A; Seifeldin IA; Ismail K; Ramadan M; El-Hamzawy H; Wilson ML; Banerjee M; Boffetta P; Harford J; Merajver SD; Soliman AS
    BJOG; 2010 Feb; 117(3):348-55. PubMed ID: 20015310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
    Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.
    Stojanovic MM; Rancic NK; Andjelković Apostolović MR; Ignjatović AM; Stojanovic DR; Mitic Lakusic VR; Ilic MV
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208629
    [No Abstract]   [Full Text] [Related]  

  • 14. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.
    Gardner AB; Charo LM; Mann AK; Kapp DS; Eskander RN; Chan JK
    Clin Exp Metastasis; 2020 Feb; 37(1):107-113. PubMed ID: 31758289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.
    Wang Z; Guo E; Yang B; Xiao R; Lu F; You L; Chen G
    Gynecol Oncol; 2021 Nov; 163(2):358-363. PubMed ID: 34507827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Descriptive epidemiology of gynecologic and breast cancers].
    Schraub S; Alauzet E; Schaffer P; Robillard J; Menegoz F
    Rev Fr Gynecol Obstet; 1992 Dec; 87(12):577-85. PubMed ID: 1485074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    Medhin LB; Tekle LA; Achila OO; Said S
    Sci Rep; 2020 Jun; 10(1):9099. PubMed ID: 32499531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
    Giudici F; De Paoli A; Toffolutti F; Guzzinati S; Francisci S; Bucchi L; Gatta G; Demuru E; Mallone S; Cin AD; Caldarella A; Cuccaro F; Migliore E; Gambino ML; Ravaioli A; Puppo A; Ferrante M; Carrozzi G; Stracci F; Musolino A; Gasparotti C; Cavallo R; Mazzucco W; Vitale MF; Cascone G; Ballotari P; Ferretti S; Mangone L; Rizzello RV; Sampietro G; Mian M; Boschetti L; Galasso R; Bella F; Piras D; Sessa A; Seghini P; Fanetti AC; Pinna P; De Angelis R; Serraino D; Maso LD;
    Am J Epidemiol; 2024 Sep; 193(9):1224-1232. PubMed ID: 38629583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.